New Class of Drugs May Treat or Prevent Diabetes
Robert Langreth, in Forbes.com, writes about a new type of drug, called an anti-CD3 antibody, which aims for the first time to delay or prevent development of diabetes by arresting the immune system's attack on pancreatic islet cells. This new class of drugs, now entering final-stage human trials, are given to newly diagnosed patients for just a few days or weeks but appear to preserve some insulin-producing capacity for years. Ultimately the drugs may even be able to prevent the disease from striking people at high risk because of a family history of diabetes or bad genes. MORE.....
